Market access is evolving faster than many organizations can adapt. In this Pharmaceutical Executive Dedicated Dialogue, Dane Schroeder discusses why “policy fatigue,” affordability pressures, and shifting payer expectations are redefining patient access. Learn why successful pharmaceutical companies are rethinking launch planning, access strategy, and cross-functional collaboration to close the gap between coverage and real-world access.